Dimension Inx

Dimension Inx, a spin-out from the Northwestern University, is a biofabrication startup that creates next-gen biomaterials and 3D-printed bioactive structures that enable organ and tissue regeneration and repair.

Dimension Inx is leading the way in the development of advanced 3D-printable materials and manufacturing processes, with application in medicine and beyond.

Dimension Inx was founded in 2017 by Caralynn Nowinski Collens, Ramille Shah and Adam Jakus. The company is headquartered in Chicago, Illinois.

 

Dimension Inx designs, develops, and manufactures therapeutic products. Enabling a new generation of regenerative therapeutics, Dimension Inx’s platform engineers three-dimensional microenvironments that direct cell behavior and allow the body to restore tissue and organ function more effectively.

 

 

Dimension Inx works shoulder-to-shoulder with biotech and medical device partners to help solve their most challenging materials problems, and internally develop medical products for various therapeutic applications ranging from bone regeneration to fertility preservation.

 

Dimension Inx has partnered with renowned universities and hospitals, like Emory University, The Children’s Hospital of Philadelphia, Carnegie Mellon University, Nanyang Technological University in Singapore, and much more.

 

Dimension Inx is backed by Prime Movers Lab (PML), KdT Ventures, Revolution’s Rise of the Rest Seed Fund (ROTR), Better Ventures, Solas BioVentures, Portal Innovation Ventures, Alumni Ventures, and others. The company raised $12M in Series A round on Feb 01, 2023. This brings Dimension Inx's total funding to $17.7M to date.

 

 

  • Year founded: 2017
  • Funding Info: $17.7M over 4 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Chicago
  • State: Illinois
  • Country: United States
Related businesses